3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
4
Other
3
Breast
3
Endocrine
2
Lymphoid
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Melanoma
346
Carcinoma, Non-Small-Cell Lung
81
Skin Neoplasms
71
Carcinoma, Renal Cell
51
Lung Neoplasms
49
Neoplasm Metastasis
47
Breast Neoplasms
45
Colorectal Neoplasms
44
Neoplasms
42
Carcinoma, Basal Cell
42
Uveal Melanoma
38
Squamous Cell Carcinoma of Head and Neck
37
Carcinoma, Merkel Cell
36
Ovarian Neoplasms
35
Sarcoma
31
Lymphoma, T-Cell, Cutaneous
31
Pancreatic Neoplasms
26
Prostatic Neoplasms
24
Carcinoma, Hepatocellular
23
Stomach Neoplasms
21
Head and Neck Neoplasms
21
Uterine Cervical Neoplasms
20
Urinary Bladder Neoplasms
20
Thyroid Neoplasms
20
Esophageal Neoplasms
19
Brain Neoplasms
18
Carcinoma, Squamous Cell
17
Mycosis Fungoides
16
Carcinoma, Transitional Cell
16
Triple Negative Breast Neoplasms
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Type 2
×
Dermatologic
×
90 days
×
Clear all
NCT04726319
2026-05-06
FHAMe
University of Toronto
Phase NA
Completed
627 enrolled